https://biotechmorning.com/news/ray-therapeutics-125m-series-b-vision-restoration Biotech Morning en 2026-04-22T14:10:48.773Z The $125M Bet on Making Blind Eyes See Again https://biotechmorning.com/news/undruggable-kras-g12d-zoldonrasib-lung-cancer Biotech Morning en 2026-04-22T14:10:07.920Z The "Undruggable" Cancer Target That Just Got Drugged https://biotechmorning.com/news/pbm-drug-price-transparency-fight Biotech Morning en 2026-04-22T14:09:25.208Z The $10,000-a-Day Fine That Has PBMs Sweating https://biotechmorning.com/news/flagship-serif-biomedicines-modified-dna-launch-2 Biotech Morning en 2026-04-22T14:08:43.760Z Flagship's New Bet: A DNA That Acts Like mRNA's Cooler, Longer-Lasting Cousin https://biotechmorning.com/news/tortugas-neuroscience-106m-cns-launch Biotech Morning en 2026-04-22T14:07:52.441Z The Sage Vets Who Raised $106M to Take Another Swing at the Brain https://biotechmorning.com/news/idvynso-two-drug-hiv-pill-fda-approval Biotech Morning en 2026-04-22T14:07:09.080Z The Two-Drug HIV Pill That Wasn't Supposed to Make It https://biotechmorning.com/news/gilead-arcus-tigit-failure-partnership-unravels Biotech Morning en 2026-04-21T14:10:03.321Z Biotech's $2 Billion Blind Date Just Ended in Tears https://biotechmorning.com/news/lilly-kelonia-7-billion-in-vivo-car-t Biotech Morning en 2026-04-21T14:09:13.777Z Lilly Just Spent $7 Billion to Skip the Hardest Part of Cancer Treatment https://biotechmorning.com/news/replimune-oncolytic-virus-layoffs-fda-rejection Biotech Morning en 2026-04-21T14:08:20.784Z The Virus That Was Supposed to Kill Cancer Just Killed a Company Instead https://biotechmorning.com/news/flagship-serif-biomedicines-modified-dna-launch Biotech Morning en 2026-04-21T14:07:37.061Z Flagship Just Invented a New Type of Drug (No, Seriously) https://biotechmorning.com/news/biogen-850m-tj-biopharma-felzartamab-china-deal Biotech Morning en 2026-04-21T14:06:49.827Z Biogen Just Paid $850M to Own a Drug You've Never Heard Of